Page last updated: 2024-08-21

benzoxazoles and Small Cell Lung Carcinoma

benzoxazoles has been researched along with Small Cell Lung Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, B; Gao, L; Guo, T; Kannan, A1
Behtaj, M; Dowlati, A; Fu, P; Kresak, A; Sakre, N; Wildey, G; Yang, M1

Other Studies

2 other study(ies) available for benzoxazoles and Small Cell Lung Carcinoma

ArticleYear
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis.
    International journal of biological sciences, 2018, Volume: 14, Issue:10

    Topics: Apoptosis; Benzoxazoles; Cell Line, Tumor; DNA Damage; Endoplasmic Reticulum Stress; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Pyrazoles; Pyrimidines; Pyrimidinones; Small Cell Lung Carcinoma; TOR Serine-Threonine Kinases

2018
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Benzamides; Benzoxazoles; Female; Fibroblast Growth Factor 10; Gene Amplification; Humans; Interleukin-7 Receptor alpha Subunit; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Morpholines; Protein Kinase Inhibitors; Pyrimidines; Rapamycin-Insensitive Companion of mTOR Protein; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome

2017